Skip Navigation LinksHome > September 2004 - Volume 104 - Issue 3 > Conservative Versus Extirpative Management in Cases of Place...
Obstetrics & Gynecology:
doi: 10.1097/01.AOG.0000136086.78099.0f
Original Research

Conservative Versus Extirpative Management in Cases of Placenta Accreta

Kayem, Gilles MD; Davy, Céline MD; Goffinet, François MD, PhD; Thomas, Carole MD; Clément, Denis MD; Cabrol, Dominique PhD

Free Access
Article Outline
Collapse Box

Author Information

From the Department of Obstetrics and Gynaecology, Maternité Port-Royal Hospital, Cochin APHP University René Descartes, Paris, France.

Address reprint requests to: Gilles Kayem, MD, Department of Obstetrics and Gynaecology, Centre Hospitalier Intercommunal de Créteil, Créteil, France; e-mail: gilles.kayem@chicreteil.fr.

Received March 12, 2004. Received in revised form May 12, 2004. Accepted May 27, 2004.

Collapse Box

Abstract

OBJECTIVE: To compare the impact of conservative and extirpative strategies for placenta accreta on maternal morbidity and mortality.

METHODS: We retrospectively reviewed the medical records of all patients diagnosed with placenta accreta admitted to our tertiary center from January 1993 through December 2002. Two consecutive periods, A and B, were compared. During period A (January 1993 to June 1997), our written protocol called for the systematic manual removal of the placenta, to leave the uterine cavity empty. In period B (July 1997 to December 2002), we changed our policy by leaving the placenta in situ. The following outcomes over the 2 periods were compared: need for blood transfusion, hysterectomy, intensive care admission, duration of stay in intensive care, and postpartum endometritis.

RESULTS: Thirty-three cases of placenta accreta were observed among 31,921 deliveries (1.03/1,000). During period B, there was a reduction in the hysterectomy rate (from 11 [84.6%] to 3 [15%]; P < .001), the mean number of red blood cells transfused (3,230 ± 2,170 mL versus 1,560 ± 1,646 mL; P < .01), and disseminated intravascular coagulation (5 [38.5%] versus 1 [5.0%]; P = .02), compared with period A. There were 3 cases of sepsis in period B and none in period A (P = .26). At least 2 women with conservative management subsequently had successful pregnancies.

CONCLUSION: Leaving the placenta accreta in situ appears to be a safe alternative to removing the placenta.

LEVEL OF EVIDENCE: II-3

Placenta accreta occurs when a defect of the decidua basalis results in abnormally invasive placental implantation.1 It is often diagnosed only after delivery when manual removal of the placenta has failed. Attempting forcible manual removal of a placenta accreta can easily lead to dramatic hemorrhaging that may result in hysterectomy. Thus, placenta accreta and especially placenta percreta have been reported to result in a mortality rate of 7% and cause intraoperative and postoperative morbidity associated with massive blood transfusions, infection, ureteral damage, and fistula formation.2 Its incidence, which is correlated with the cesarean rate, has increased 10-fold in the past 50 years.3 With a frequency of approximately 1 per 1,000 deliveries, this disorder has become more common in our medical practice.4

Case reports describe several methods for decreasing blood loss after delivery and preserving the uterus: uterine packing, oversewing the placental bed, leaving the placenta in situ, prostaglandin administration, direct aortic compression, uterine and hypogastric artery ligation, methotrexate injection, selective embolization procedures, and argon beam coagulation.5–7

Until mid-1997, the “gold standard” for the management of placenta accreta in our tertiary referral center was an extirpative approach, in accordance with most recommendations from Europe and North America.8 In July of that year, we changed this strategy and agreed unanimously to modify our hospital protocol. This decision was based on several published case reports and followed the successful conservative management of one case of placenta accreta, by leaving the placenta in place.9 We began to treat most cases of placenta accreta conservatively, leaving in situ each placenta that adhered either partially or totally to the myometrium. The purpose of this study was to evaluate the impact of this conservative management on hysterectomy and maternal morbidity rates.

Back to Top | Article Outline

MATERIALS AND METHODS

We retrospectively reviewed the medical records of all patients admitted to our tertiary center with a diagnosis of placenta accreta, increta, or percreta during the decade from January 1993 through December 2002. Gestational age was generally estimated by ultrasound dating and otherwise measured from the first day of the last menstrual period. We included all women who delivered at our hospital after 22 weeks of gestation.

To simplify the analysis, we treated all abnormal placentation including the variants of placenta increta and percreta as accreta. We diagnosed placenta accreta according to clinical or histologic criteria as follows10: 1) manual removal of the placenta partially or totally impossible and no cleavage plane between part or all of the placenta and the uterus, 2) heavy bleeding from the implantation site after forced placental removal during cesarean delivery, 3) histologic confirmation of accreta on a hysterectomy specimen, and 4) prenatal diagnosis of placenta accreta confirmed by the failure of its gentle attempted removal during the third stage of labor.

We compared 2 periods: January 1993 to June 1997 (period A) and July 1997 to December 2002 (period B). During period A, our written protocol called for the systematic manual removal of the placenta to leave the uterine cavity empty, even if force was required. In period B, we changed our policy and attempted to treat patients with placenta accreta conservatively.

We used 2 different types of conservative treatment, depending on how the placenta accreta was discovered. When it was discovered during delivery, removal of the placenta was not forced; the conservative treatment left the placenta, in part or entirely, in the uterus when the patient's hemodynamic status was stable and no septic risk was present. When the placenta accreta was strongly suspected before delivery (based on history and ultrasound or magnetic resonance imaging suggestive of the diagnosis), the case was discussed at the weekly obstetrical staff meeting and conservative treatment proposed to the patient.

In this case, management included the following steps. The precise position of the placenta was determined by ultrasound. A cesarean was planned, with the abdominal incision at the infraumbilical midline, enlarged above the umbilicus if necessary, and a vertical uterine incision at a distance from the placental insertion. After extraction of the infant, delivery of the placenta was attempted prudently, with the injection of 5 IU oxytocin and moderate cord traction. If this failed, the placenta was considered to be “accreta” and left in situ. The cord was cut at the placental insertion and the placenta left in the uterine cavity; the uterine incision was closed. Prophylactic antibiotic therapy (amoxicillin and clavulanic acid) was administered systematically for 10 days.

During the postpartum period, all patients were evaluated weekly for 6 months with ultrasonography, clinical examination, and blood counts. To improve clinical follow-up and to help choose antibiotic therapy in cases of endometritis with or without sepsis, C-reactive protein was assayed, and vaginal samples were taken for bacteriologic study.

Maternal morbidity was assessed with the following indicators: need for blood (or blood product) transfusion, hysterectomy, intensive care admission, duration of stay in intensive care, disseminated intravascular coagulation (defined by platelet count of less than 100,000 per cubic millimeter or a rapid decline in the platelet count; prolongation of clotting times, such as the prothrombin time and the activated partial-thromboplastin time; the presence of fibrin-degradation products in plasma; and low plasma levels of coagulation inhibitors, such as antithrombin III), and postpartum endometritis (defined by fever of more than 38.0°C and pelvic pain suggestive of the diagnosis) with or without sepsis (defined by positive blood culture).

The anesthetist and obstetrician jointly decided upon the transfusion of packed red blood cells or fresh frozen plasma, according to the mother's hemodynamic situation, the extent of blood loss, and the risk of hemorrhage. The transfusion policy did not change between the periods.

Univariate analysis was conducted with Fisher exact test for categorical variables and the Mann-Whitney U test for continuous variables.

Back to Top | Article Outline

RESULTS

From 1993 through 2002, 31,921 deliveries occurred at our center. Thirty-three women (1.03/1,000) satisfied our diagnostic criteria, and their charts were reviewed for their medical and pregnancy history and their exposure to potential risk factors. Table 1 summarizes the characteristics of this population. The groups did not differ significantly in age, parity, or type of delivery. In all, 17 patients either went into spontaneous preterm labor or had vaginal bleeding before term. The ensuing spontaneous or induced preterm births resulted in a mean estimated gestational age of 33.8 weeks at delivery for the 33 patients.

Table 1
Table 1
Image Tools

Table 2 summarizes the patients’ risk factors. Placenta previa was observed in 20 patients (60.6%). The groups did not differ significantly for these risk factors. All but one patient had a history of at least one risk factor (Table 2).

Table 2
Table 2
Image Tools

Figure 1 shows the 2 groups and the treatment received, including the number of hysterectomies. Table 3 describes outcomes for all patients. Thirteen cases (0.93/1,000 deliveries) of placenta accreta occurred during period A, only one of which was diagnosed prenatally. Only 2 patients did not have a hysterectomy during this period. For the first patient, the forcible removal of the entire placenta caused moderate hemorrhaging that was controlled by embolization of both uterine arteries. For the second patient, a small part of placenta remained accreta, despite the attempt to remove it forcibly, and was finally left in the uterus and treated conservatively.

Fig. 1
Fig. 1
Image Tools
Table 3
Table 3
Image Tools

Twenty cases (1.11/1,000 deliveries) of placenta accreta occurred during period B. Two women had a placenta percreta with localized bladder invasion; conservative management for them was successful. Fifteen cases were discovered at delivery and managed conservatively, with the placenta left partially or totally in place. Four cases of placenta accreta suspected prenatally were confirmed during the cesarean and managed conservatively, with the placenta left totally in place. Only one multiparous patient, with a diagnosis of placenta accreta suspected prenatally, preferred surgical management in case of intraoperative confirmation; she had a hysterectomy. Two other patients underwent hysterectomies during period B. One involved forcible removal, in a case where the surgeon did not suspect placenta accreta; massive hemorrhage led to a hysterectomy. The second patient had a hysterectomy on day 26 because of severe endometritis and a recurrence of hemorrhage, although conservative treatment was initially successful.

The retained placenta was measured along the horizontal axis of the uterus by ultrasonography within 2 days of delivery (median 40 mm, range 10–100). All the patients treated conservatively were carefully monitored on a weekly basis until complete ultrasonographic resorption of the placenta, at a mean of 6 months (3–12 months). One patient was admitted to our department for uterine bleeding and contractions 15 days after delivery. Clinical examination showed that the cervix was fully dilated and the placenta partially expelled into the vagina. The delivered part of the placenta was therefore removed after surgical excision. The other women in group B had spotting until complete resorption of the placenta. Six cases of postpartum endometritis, 3 involving blood-culture–confirmed sepsis, were treated successfully with hospitalization and appropriate intravenous antibiotics. Surgical evacuation was not performed in any of these cases.

The comparison of the 2 periods shows fewer cases of hysterectomy, transfusion, and disseminated intravascular coagulation during period B than during period A (Table 3). The hysterectomy rate decreased between 1993 and 2002, although the number of cases of placenta accreta was higher during period B. Sulprostone was administered to 11 patients (85%) during period A and 16 (80%) during period B (P = .99). We performed one uterine artery embolization and one hypogastric artery ligation during period A, and one hypogastric artery ligation and 5 uterine artery embolizations during period B (P = .43).

Seven patients in group B were contacted from 1 to 5 years afterward, whereas 10 were lost to long-term follow-up. Of these 7 patients, one had another successful pregnancy 2 years later and another had 2 consecutive successful pregnancies, both complicated by placenta accreta treated conservatively. The others chose for various personal reasons not to become pregnant again. None sought subsequent treatment for sterility.

Back to Top | Article Outline

DISCUSSION

This study is a historical consecutive study comparing conservative and extirpative management of placenta accreta in a single center with consistent treatment protocols.

The approach most often recommended in cases of placenta accreta is extirpative.4 If risk factors and prenatal imaging together strongly suggest this diagnosis, a cesarean hysterectomy is generally planned, especially for patients who do not wish continued fertility. If the placenta accreta is discovered after delivery, the placenta is removed as soon as possible to empty the uterine cavity. In most cases, however, this forced delivery induces massive hemorrhaging and leads to hysterectomy. Moreover, when the placenta is percreta, the surgery can cause ablation of contiguous organs and thus substantial maternal morbidity, in addition to a mortality rate of approximately 7%.2

An alternative therapeutic approach is conservative rather than extirpative. Some cases of successful conservative management of placenta accreta have previously been reported,6,11–13 although they were counterbalanced by the hemorrhagic and infectious complications that sometimes occurred.14,15 Moreover, case reports, although useful for suggesting new management approaches, cannot be used to assess them and do not allow the benefits and disadvantages of each therapeutic strategy to be evaluated comparatively. Similarly, the risk of complications cannot be estimated accurately from a few published case reports.

Our study compared 2 periods during which 2 different treatment strategies were applied. To minimize the inclusion bias, the study included all patients with placenta accreta over a 10-year period. The comparison was based solely on the period and not on the type of treatment strategy. Nonetheless, our results show that a policy of conservative management–even although extirpative treatment was performed in some cases–decreased the hysterectomy and maternal morbidity rates and preserved childbearing ability.

Nonetheless, although our results support the use of conservative management to improve the outcome in selected patients, several questions remain unresolved. These include the optimal adjuvant management, the best prenatal imaging methods for diagnosis, the long-term prognosis, and the risk of rare and grave maternal morbidity or mortality.

Methotrexate, uterine artery embolization, and sulprostone are 3 adjuvant treatments described in several case reports involving conservative treatment.6,14,16–18 The outcome when the placenta is left in place after methotrexate administration varies widely; it ranges from expulsion at 7 days to progressive resorption in roughly 6 months.6,16–18 Similarly, only a few reports describe the outcome after embolization and leaving the placenta in situ.19 We embolized the uterine arteries in some cases, to diminish or prevent a postpartum hemorrhage, and did not use methotrexate at all. Sulprostone is a well-known uterotonic agent used in case of postpartum hemorrhage. It was used in period A to attempt to avoid hysterectomy and in period B in most cases to prevent or to treat immediate abnormal postpartum bleeding, particularly in case of substantial placental retention. Published reports do not currently prove the benefit of adding these two therapies to conservative treatment, but we preferred to use them to try to prevent major postpartum bleeding in the 2 or 3 days after delivery. Prenatal identification of placenta accreta would make it much easier to take the appropriate precautions and to make choices about delivery in advance. However, the sensitivity and specificity of transvaginal or transabdominal ultrasound and magnetic resonance imaging vary from 33% to 95% in different studies; they depend especially on placenta location.8,20–22 For these reasons, imaging should be considered only when placenta accreta is suspected for clinical reasons. In our practice, we systematically attempt a careful and gentle intraoperative delivery of the placenta to confirm the diagnosis, even when placenta accreta is strongly suspected before labor.

Conservative management had some disadvantages, including postpartum infection, treatment failure, and restrictive follow-up. Ideally, these should be discussed prenatally with the patient to give her complete information about the different therapeutic strategies (extirpative or conservative). Given the difficulties mentioned above for prenatal diagnosis, however, this discussion is rarely possible. Accordingly, we have always attempted to preserve maternal fertility and to diminish the risk of hemorrhage when placenta accreta is discovered during delivery.

In our study, conservative management of placenta accreta was associated with a reduction of severe postpartum hemorrhaging and hysterectomies. These results are promising and indicate that this treatment can be considered in selected cases of women without massive postpartum hemorrhage and desirous of future fertility. Thus, at least 2 of the women followed up in group B had subsequent successful pregnancies.

This strategy must be applied with discrimination, however. The number of patients included in the second period is too low for an adequate evaluation of the risk of rare severe maternal morbidity or mortality. Accordingly, this type of management is presently appropriate only when rigorous monitoring will follow, in centers with adequate equipment and resources.8

Back to Top | Article Outline

REFERENCES

1. Khong TY, Robertson WB. Placenta creta and placenta praevia creta. Placenta 1987;8:399–409.

2. O'Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol 1996;175:1632–8.

3. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 1997;177:210–4.

4. Placenta accreta. ACOG Committee Opinion No. 266. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002;77:77–8.

5. Scarantino SE, Reilly JG, Moretti ML, Pillari VT. Argon beam coagulation in the management of placenta accreta. Obstet Gynecol 1999;94:825–7.

6. Mussalli GM, Shah J, Berck DJ, Elimian A, Tejani N, Manning FA. Placenta accreta and methotrexate therapy: three case reports. J Perinatol 2000;20:331–4.

7. Johanson R, Kumar M, Obhrai M, Young P. Management of massive postpartum haemorrhage: use of a hydrostatic balloon catheter to avoid laparotomy. BJOG 2001;108:420–2.

8. American College of Obstetricians and Gynecologists. Postpartum hemorrhage. ACOG Educational Bulletin 243. Washington, DC: ACOG; 1998.

9. Kayem G, Pannier E, Goffinet F, Grange G, Cabrol D. Fertility after conservative treatment of placenta accreta. Fertil Steril 2002;78:637–8.

10. Gielchinsky Y, Rojansky N, Fasouliotis SJ, Ezra Y. Placenta accreta—summary of 10 years: a survey of 310 cases. Placenta 2002;23:210–4.

11. Legro RS, Price FV, Hill LM, Caritis SN. Nonsurgical management of placenta percreta: a case report. Obstet Gynecol 1994;83:847–9.

12. Hollander DI, Pupkin MJ, Crenshaw MC, Nagey DA. Conservative management of placenta accreta: a case report. J Reprod Med 1988;33:74–8.

13. Komulainen MH, Vayrynen MA, Kauko ML, Saarikoski S. Two cases of placenta accreta managed conservatively. Eur J Obstet Gynecol Reprod Biol 1995;62:135–7.

14. Jaffe R, Dubeshter B, Sherer DM, Thompson EA, Woods JR. Failure of methotrexate treatment for term placenta percreta. Am J Obstet Gynecol 1994;171:558–9.

15. Butt K, Gagnon A, Delisle MF. Failure of methotrexate and internal iliac balloon catheterization to manage placenta percreta. Obstet Gynecol 2002;99:981–2.

16. Arulkumaran S, Ng CS, Ingemarsson I, Ratnam SS. Medical treatment of placenta accreta with methotrexate. Acta Obstet Gynecol Scand 1986;65:285–6.

17. Buckshee K, Dadhwal V. Medical management of placenta accreta. Int J Gynaecol Obstet 1997;59:47–8.

18. Gupta D, Sinha R. Management of placenta accreta with oral methotrexate. Int J Gynaecol Obstet 1998;60:171–3.

19. Lemercier E, Genevois A, Descargue G, Clavier E, Benozio M. MRI evaluation of placenta accreta treated by embolization—apropos of a case: review of the literature [in French]. J Radiol 1999;80:383–7.

20. Lam G, Kuller J, Mcmahon M. Use of magnetic resonance imaging and ultrasound in the antenatal diagnosis of placenta accreta. J Soc Gynecol Investig 2002;9:37–40.

21. Finberg HJ, Williams JW. Placenta accreta: prospective sonographic diagnosis in patients with placenta previa and prior cesarean section. J Ultrasound Med 1992;11:333–43.

22. Levine D, Hulka CA, Ludmir J, Li W, Edelman RR. Placenta accreta: evaluation with color Doppler US, power Doppler US, and MR imaging. Radiology 1997;205:773–6.

Cited By:

This article has been cited 56 time(s).

Gynecologie Obstetrique & Fertilite
Placenta accreta: Screening, management and complications
Hequet, D; Ricbourg, A; Sebbag, D; Rossignol, M; Lubrano, S; Barranger, E
Gynecologie Obstetrique & Fertilite, 41(1): 31-37.
10.1016/j.gyobfe.2012.11.001
CrossRef
European Radiology
Placental vascularity and resorption delay after conservative management of invasive placenta: MR imaging evaluation
Soyer, P; Sirol, M; Fargeaudou, Y; Bour, L; Morel, O; Dohan, A; Boudiaf, M; Gayat, E; Hequet, D; Barranger, E; le Dref, O
European Radiology, 23(1): 262-271.
10.1007/s00330-012-2573-4
CrossRef
Journal De Gynecologie Obstetrique Et Biologie De La Reproduction
Women with previous caesarean or other uterine scar: Epidemiological features
Deneux-Tharaux, C
Journal De Gynecologie Obstetrique Et Biologie De La Reproduction, 41(8): 697-707.
10.1016/j.jgyn.2012.09.022
CrossRef
Gynecologie Obstetrique & Fertilite
Management of placenta accreta
Kayem, G; Grange, G; Goffinet, F
Gynecologie Obstetrique & Fertilite, 35(3): 186-192.
10.1016/j.gyobfe.2007.01.021
CrossRef
Bjog-An International Journal of Obstetrics and Gynaecology
Radiofrequency ablation of retained placenta accreta after conservative management: preliminary evaluation in the pregnant ewe and in normal human placenta in vitro
Morel, O; Monceau, E; Tran, N; Malartic, C; Morel, F; Barranger, E; Cote, JF; Gayat, E; Chavatte-Palmer, P; Cabrol, D; Tsatsaris, V
Bjog-An International Journal of Obstetrics and Gynaecology, 116(7): 915-922.
10.1111/j.1471-0528.2009.02166.x
CrossRef
International Journal of Gynecology & Obstetrics
Fertility and obstetric outcome after conservative management of placenta accreta
Provansal, M; Courbiere, B; Agostini, A; D'Ercole, C; Boubli, L; Bretelle, F
International Journal of Gynecology & Obstetrics, 109(2): 147-150.
10.1016/j.ijgo.2009.12.011
CrossRef
Obstetrical & Gynecological Survey
Abnormal Placental Invasion-a Novel Approach to Treatment Case Report and Review
Ophir, E; Singer-Jordan, J; Odeh, M; Hirch, Y; Maksimovsky, O; Shaider, O; Yvry, S; Solt, I; Bornstein, J
Obstetrical & Gynecological Survey, 64(): 811-822.

Ultrasound in Obstetrics & Gynecology
Ultrasonographic findings in conservatively treated placenta percreta
Wong, HS; Parker, S
Ultrasound in Obstetrics & Gynecology, 26(5): 580-581.
10.1002/uog.2583
CrossRef
Journal De Gynecologie Obstetrique Et Biologie De La Reproduction
Placenta accreta: what care?
Kayem, G
Journal De Gynecologie Obstetrique Et Biologie De La Reproduction, 37(2): 17-18.

Journal of Obstetrics and Gynaecology Research
Results of endovascular treatment in cases of abnormal placentation with post-partum hemorrhage
La Folie, T; Vidal, V; Mehanna, M; Capelle, M; Jaquier, A; Moulin, G; Bartoli, JM
Journal of Obstetrics and Gynaecology Research, 33(5): 624-630.
10.1111/j.1447-0756.2007.00622.x
CrossRef
Best Practice & Research in Clinical Obstetrics & Gynaecology
Uterine artery embolization for postpartum hemorrhage
Winograd, RH
Best Practice & Research in Clinical Obstetrics & Gynaecology, 22(6): 1119-1132.
10.1016/j.bpobgyn.2008.08.009
CrossRef
Bjog-An International Journal of Obstetrics and Gynaecology
Optimal management strategies for placenta accreta Authors' Reply
Carcopino, X; d'Ercole, C; Bretelle, F
Bjog-An International Journal of Obstetrics and Gynaecology, 116(): 1538.
10.1111/j.1471-0528.2009.02249.x
CrossRef
Journal of Perinatal Medicine
Failure of conservative management of placenta previa-percreta
Luo, GY; Perni, SC; Jean-Pierre, C; Baergen, RN; Predanic, M
Journal of Perinatal Medicine, 33(6): 564-568.
10.1515/JPM.2005.101
CrossRef
Ultrasound in Obstetrics & Gynecology
Placenta previa percreta managed conservatively with methotrexate and multiple bilateral uterine artery embolizations
Sherer, DM; Gorelick, C; Zigalo, A; Sclafani, S; Zinn, HL; Abulafia, O
Ultrasound in Obstetrics & Gynecology, 30(2): 227-228.
10.1002/uog.4075
CrossRef
International Journal of Gynecology & Obstetrics
Differences in the management of suspected cases of placenta accreta in France and Argentina
Mazouni, C; Palacios-Jaraquemada, JM; Deter, R; Juhan, V; Gamerre, M; Bretelle, F
International Journal of Gynecology & Obstetrics, 107(1): 1-3.
10.1016/j.ijgo.2009.04.021
CrossRef
American Journal of Perinatology
Prophylactic Pelvic Artery Catheterization and Embolization in Women with Placenta Accreta: Can It Prevent Cesarean Hysterectomy?
Sivan, E; Spira, M; Achiron, R; Rimon, U; Golan, G; Mazaki-Tovi, S; Schiff, E
American Journal of Perinatology, 27(6): 455-461.
10.1055/s-0030-1247599
CrossRef
American Journal of Obstetrics and Gynecology
Extirpative or conservative management for placenta percreta?
Sentilhes, L; Resch, B; Clavier, E; Marpeau, L
American Journal of Obstetrics and Gynecology, 195(6): 1875-1876.
10.1016/j.ajog.2006.02.003
CrossRef
Placenta
Placenta accreta: A review of current advances in prenatal diagnosis
Mazouni, C; Gorincour, G; Juhan, V; Bretelle, F
Placenta, 28(7): 599-603.
10.1016/j.placenta.2006.06.011
CrossRef
European Journal of Obstetrics Gynecology and Reproductive Biology
Management of placenta accreta: Morbidity and outcome
Bretelle, F; Courbiere, B; Mazouni, C; Agostini, A; Cravello, L; Boubli, L; Gamerre, M; D'Ercole, C
European Journal of Obstetrics Gynecology and Reproductive Biology, 133(1): 34-39.
10.1016/j.ejogrb.2006.07.050
CrossRef
Bjog-An International Journal of Obstetrics and Gynaecology
Fertility and pregnancy following pelvic arterial embolisation for postpartum haemorrhage
Sentilhes, L; Gromez, A; Clavier, E; Resch, B; Verspyck, E; Marpeau, L
Bjog-An International Journal of Obstetrics and Gynaecology, 117(1): 84-93.
10.1111/j.1471-0528.2009.02381.x
CrossRef
Ultrasound in Obstetrics & Gynecology
From obstetric ultrasound to ultrasonographic obstetrics
Ville, Y
Ultrasound in Obstetrics & Gynecology, 27(1): 1-5.

Gynecologie Obstetrique & Fertilite
Interest of modern imagery for conservative management of a placenta percreta
Bader, G; Jelen, H; Quarello, E; Guyot, B; Limot, O; Ville, Y
Gynecologie Obstetrique & Fertilite, 35(2): 142-148.
10.1016/S1297-9589(06)00521-2
CrossRef
Australian & New Zealand Journal of Obstetrics & Gynaecology
Conservative management of clinically diagnosed placenta accreta following vaginal delivery
Bennett, MJ; Townsend, L
Australian & New Zealand Journal of Obstetrics & Gynaecology, 49(6): 647-649.
10.1111/j.1479-828X.2009.01090.x
CrossRef
Ultraschall in Der Medizin
Diagnosis, Treatment and Application of Color Doppler in Conservative Management of Abnormally Adherent Placenta
Merz, W; Van de Vondel, P; Strunk, H; Geipel, A; Gembruch, U
Ultraschall in Der Medizin, 30(6): 571-576.
10.1055/s-2008-1027701
CrossRef
International Journal of Gynecology & Obstetrics
B-Lynch suture, intrauterine balloon, and endouterine hemostatic suture for the management of postpartum hemorrhage due to placenta previa accreta
Arduini, M; Epicoco, G; Clerici, G; Bottaccioli, E; Arena, S; Affronti, G
International Journal of Gynecology & Obstetrics, 108(3): 191-193.
10.1016/j.ijgo.2009.10.007
CrossRef
Journal of Reproductive Medicine
Abnormal placental invasion - Experience at 1 center
Bencaiova, G; Burkhardt, T; Beinder, E
Journal of Reproductive Medicine, 52(8): 709-714.

Gynecologie Obstetrique & Fertilite
Placenta accreta care - Response of O. Morel, D. Clement and E. Barranger at article of G. Kayem et al
Morel, O; Clement, D; Barranger, E
Gynecologie Obstetrique & Fertilite, 35(): 707-708.

International Journal of Gynecology & Obstetrics
Recurrence following conservative management of placenta accreta
Kayem, G; Clement, D; Goffinet, F
International Journal of Gynecology & Obstetrics, 99(2): 142-143.
10.1016/j.ijgo.2007.05.035
CrossRef
Journal of Obstetrics and Gynaecology Research
Placenta previa increta/percreta in Japan: A retrospective study of ultrasound findings, management and clinical course
Sumigama, S; Itakura, A; Ota, T; Okada, M; Kotani, T; Hayakawa, H; Yoshida, K; Ishikawa, K; Hayashi, K; Kurauchi, O; Yamada, S; Nakamura, H; Matsusawa, K; Sakakibara, K; Ito, M; Kawai, M; Kikkawa, F
Journal of Obstetrics and Gynaecology Research, 33(5): 606-611.
10.1111/j.1447-0756.2007.00619.x
CrossRef
American Journal of Roentgenology
Perioperative endovascular internal iliac artery occlusion balloon placement in management of placenta accreta
Tan, CH; Tay, KH; Sheah, K; Kwek, K; Wong, K; Tan, HK; Tan, BS
American Journal of Roentgenology, 189(5): 1158-1163.
10.2214/AJR.07.2417
CrossRef
Obstetrics and Gynecology
Conservative management of placenta percreta - Experiences in two cases
Hays, AME; Worley, KC; Roberts, SR
Obstetrics and Gynecology, 112(2): 425-426.

Bjog-An International Journal of Obstetrics and Gynaecology
Optimal management strategies for placenta accreta
Eller, AG; Porter, TF; Soisson, P; Silver, RM
Bjog-An International Journal of Obstetrics and Gynaecology, 116(5): 648-654.
10.1111/j.1471-0528.2008.02037.x
CrossRef
Gynecologie Obstetrique & Fertilite
Author's response: placenta accreta: diagnostic and therapeutic point of view
Kayem, G
Gynecologie Obstetrique & Fertilite, 35(): 708-710.

American Journal of Obstetrics and Gynecology
Surgical management of placenta accreta: a cohort series and suggested approach
Angstmann, T; Gard, G; Harrington, T; Ward, E; Thomson, A; Giles, W
American Journal of Obstetrics and Gynecology, 202(1): -.
ARTN 38.e1
CrossRef
Gynaecology, Obstetrics, and Reproductive Medicine in Daily Practice
Surgical treatment of postpartum haemorrhage
Bruinse, HW; Metz, GCH; Kwee, A
Gynaecology, Obstetrics, and Reproductive Medicine in Daily Practice, 1279(): 369-375.
10.1016/j.ics.2004.12.031
CrossRef
Ultrasound in Obstetrics & Gynecology
Picture of the month - Antenatal diagnosis of non-previa placenta increta with histological confirmation
Wong, HS; Zuccollo, J; Parker, S; Burns, K; Tait, J; Pringle, KC
Ultrasound in Obstetrics & Gynecology, 27(4): 467-469.
10.1002/uog.2759
CrossRef
American Journal of Obstetrics and Gynecology
Morbidity associated with nonemergent hysterectomy for placenta accreta
Hoffman, MS; Karlnoski, RA; Mangar, D; Whiteman, VE; Zweibel, BR; Lockhart, JL; Camporesi, EM
American Journal of Obstetrics and Gynecology, 202(6): -.
ARTN 628.e1
CrossRef
Ultrasound in Obstetrics & Gynecology
Antenatal diagnosis of placenta accreta: a review
Comstock, CH
Ultrasound in Obstetrics & Gynecology, 26(1): 89-96.
10.1002/uog.1926
CrossRef
International Journal of Gynecology & Obstetrics
Manual removal of suspected placenta accreta at cesarean hysterectomy
Yap, YY; Perrin, LC; Pain, SR; Wong, SF; Chan, FY
International Journal of Gynecology & Obstetrics, 100(2): 186-187.
10.1016/j.ijgo.2007.07.018
CrossRef
Singapore Medical Journal
Conservative management of placenta accreta: review of three cases
Tong, SYP; Tay, KH; Kwek, YCK
Singapore Medical Journal, 49(6): E156-E159.

Journal of Ultrasound in Medicine
Postpartum management of placenta previa accreta left in situ - Role of 3-dimensional angiography
Most, OL; Singer, T; Buterman, I; Monteagudo, A; Timor-Tritsch, IE
Journal of Ultrasound in Medicine, 27(9): 1375-1380.

Taiwanese Journal of Obstetrics & Gynecology
Failure of Conservative Treatment for Placenta Increta
Liao, CY; Ding, DC
Taiwanese Journal of Obstetrics & Gynecology, 48(3): 302-304.

Acta Obstetricia Et Gynecologica Scandinavica
Surgical management of placenta accreta: a 10-year experience
Tan, SEG; Jobling, TW; Wallace, EM; Mcneilage, LJ; Manolitsas, T; Hodges, RJ
Acta Obstetricia Et Gynecologica Scandinavica, 92(4): 445-450.
10.1111/aogs.12075
CrossRef
Acta Obstetricia Et Gynecologica Scandinavica
PACCRETA: Clinical situations at high risk of Placenta ACCRETA/Percreta: impact of diagnostic methods and management on maternal morbidity
Kayem, G; Deneux-Tharaux, C; Sentilhes, L
Acta Obstetricia Et Gynecologica Scandinavica, 92(4): 476-482.
10.1111/aogs.12078
CrossRef
Journal of Maternal-Fetal & Neonatal Medicine
Conservative management of placenta previa complicated by abnormal placentation
Breborowicz, GH; Markwitz, W; Gaca, M; Koziolek, A; Ropacka-Lesiak, M; Dera, A; Brych, M; Szymankiewicz-Breborowicz, M; Kruszynski, G; Gruca-Stryjak, K; Madejczyk, M; Szpera-Gozdziewicz, A; Krzyscin, M
Journal of Maternal-Fetal & Neonatal Medicine, 26(): 1012-1015.
10.3109/14767058.2013.766708
CrossRef
Bjog-An International Journal of Obstetrics and Gynaecology
Transverse uterine fundal incision for placenta praevia with accreta, involving the entire anterior uterine wall: a case series
Kotsuji, F; Nishijima, K; Kurokawa, T; Yoshida, Y; Sekiya, T; Banzai, M; Minakami, H; Udagawa, Y
Bjog-An International Journal of Obstetrics and Gynaecology, 120(9): 1144-1149.
10.1111/1471-0528.12252
CrossRef
Acta Obstetricia Et Gynecologica Scandinavica
Management of placenta accreta
Sentilhes, L; Goffinet, F; Kayem, G
Acta Obstetricia Et Gynecologica Scandinavica, 92(): 1125-1134.
10.1111/aogs.12222
CrossRef
American Journal of Obstetrics and Gynecology
Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births
Eshkoli, T; Weintraub, AY; Sergienko, R; Sheiner, E
American Journal of Obstetrics and Gynecology, 208(3): -.
ARTN 219.e1
CrossRef
Obstetrics & Gynecology
Conservative Versus Extirpative Management in Cases of Placenta Accreta
Fiori, O; Berkane, N; Uzan, S
Obstetrics & Gynecology, 105(1): 219-220.
10.1097/01.AOG.0000150443.23143.fc
PDF (214) | CrossRef
Obstetrics & Gynecology
Conservative Versus Extirpative Management in Cases of Placenta Accreta
Kayem, G
Obstetrics & Gynecology, 105(1): 220.
10.1097/01.AOG.0000150444.30767.27
PDF (214) | CrossRef
Obstetrics & Gynecology
Conservative Versus Extirpative Management in Cases of Placenta Accreta
Kayem, G; Davy, C; Goffinet, F; Thomas, C; Clément, D; Md, DC
Obstetrics & Gynecology, 105(1): 220-221.
10.1097/01.AOG.0000149841.23689.64
PDF (214) | CrossRef
Obstetrics & Gynecology
Effect of Predelivery Diagnosis in 99 Consecutive Cases of Placenta Accreta
Warshak, CR; Ramos, GA; Eskander, R; Benirschke, K; Saenz, CC; Kelly, TF; Moore, TR; Resnik, R
Obstetrics & Gynecology, 115(1): 65-69.
10.1097/AOG.0b013e3181c4f12a
PDF (185) | CrossRef
Obstetrics & Gynecology
Maternal Outcome After Conservative Treatment of Placenta Accreta
Sentilhes, L; Ambroselli, C; Kayem, G; Provansal, M; Fernandez, H; Perrotin, F; Winer, N; Pierre, F; Benachi, A; Dreyfus, M; Bauville, E; Mahieu-Caputo, D; Marpeau, L; Descamps, P; Goffinet, F; Bretelle, F
Obstetrics & Gynecology, 115(3): 526-534.
10.1097/AOG.0b013e3181d066d4
PDF (549) | CrossRef
Obstetrics & Gynecology
Placenta Previa, Placenta Accreta, and Vasa Previa
Oyelese, Y; Smulian, JC
Obstetrics & Gynecology, 107(4): 927-941.
10.1097/01.AOG.0000207559.15715.98
PDF (1715) | CrossRef
Obstetrics & Gynecology
Predictors of Failed Pelvic Arterial Embolization for Severe Postpartum Hemorrhage
Sentilhes, L; Gromez, A; Clavier, E; Resch, B; Verspyck, E; Marpeau, L
Obstetrics & Gynecology, 113(5): 992-999.
10.1097/AOG.0b013e3181a114f7
PDF (623) | CrossRef
Obstetrical & Gynecological Survey
Conservative Management of Abnormally Invasive Placentation
Timmermans, S; van Hof, AC; Duvekot, JJ
Obstetrical & Gynecological Survey, 62(8): 529-539.
10.1097/01.ogx.0000271133.27011.05
PDF (678) | CrossRef
Back to Top | Article Outline

© 2004 The American College of Obstetricians and Gynecologists

Login

Article Tools

Images

Share